These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953 [TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis. Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122 [TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Grados M; Scahill L; Riddle MA Child Adolesc Psychiatr Clin N Am; 1999 Jul; 8(3):617-34, x. PubMed ID: 10442233 [TBL] [Abstract][Full Text] [Related]
16. [Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system]. Baving L; Schmidt MH Z Kinder Jugendpsychiatr Psychother; 2000 Feb; 28(1):35-44. PubMed ID: 10746297 [TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence. Hammerness PG; Vivas FM; Geller DA J Pediatr; 2006 Feb; 148(2):158-65. PubMed ID: 16492422 [No Abstract] [Full Text] [Related]
18. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191 [TBL] [Abstract][Full Text] [Related]
19. A longitudinal event-related potential study of selective serotonin reuptake inhibitor therapy in treatment-naïve pediatric obsessive compulsive disorder patients. Yamamuro K; Ota T; Iida J; Kishimoto N; Nakanishi Y; Matsuura H; Uratani M; Okazaki K; Kishimoto T Psychiatry Res; 2016 Nov; 245():217-223. PubMed ID: 27552672 [TBL] [Abstract][Full Text] [Related]
20. The first Japanese pediatric case of obsessive-compulsive disorder who responded to a selective serotonin re-uptake inhibitor. Furusho J; Kubagawa T; Saitoh N; Matsuzaki K; Yamakawa H; Iikura Y Pediatr Int; 2000 Aug; 42(4):451-2. PubMed ID: 10986886 [No Abstract] [Full Text] [Related] [Next] [New Search]